Identification of a gene encoding a melanoma tumor antigen recognized by hla-a31-restricted tumor-infiltrating lymphocytes

Journal of Experimental Medicine

Volumn 181, Issue 2, 1995, Pages 799-804

  Wang, Rong Fu ^a   Robbins, Paul F ^a   Kawakami, Yutaka ^a   Kang, Xiao Qiang ^a   Kosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN; HLA A ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MELANOMA; MOLECULAR CLONING; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, NEOPLASM; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HLA-A ANTIGENS; HUMAN; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; TUMOR CELLS, CULTURED;

EID: 0028906594     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.181.2.799     Document Type: Article

References (35)

1. Rosenberg, S.A., B.S. Packard, P.M. Aebersold, D. Solomon, S.L. Topalian, S.T. Toy, P. Simon, M.T. Lotze, J.C. Yang, C.A. Seipp, C. Simpson, C. Carter, S. Bock, D. Schwartzentruber, J.P. Wei, and D.E. White. 1988. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report. N. Engl.J. Med. 319: 1676-1680.
2. Rosenberg, S.A. 1992. The immunotherapy and gene therapy of cancer. J. Clin. Oncol. 10: 180-199.
3. Boon, T., P. Weynabts, P. Coulie, T. Wolfel, M. Marchand, and V. Brichard. 1994. Genes coding for tumor rejection agents: Perspective for specific immunotherapy. In Biologic Therapy of Cancer Updates. V.T. DeVita, S. Heilman, and S.A. Rosenberg, editors. J.B. Lippincott Co., Philadelphia, PA. 2-3.
4. Herin, M., C. Lemoine, P. Weynants, F. Vessiere, A. Van Pel, A. Knuth, R. Devos, and T. Boon. 1987. Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer. 15: 390-396.
5. Crowley, N.J., C.L. Slingluff, Jr., T.L. Darrow, and H.F. Sei-gler. 1990. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas. Cancer Res. 50: 492-498.
6. Ibpalian, S.L., D. Solomon, and S.A. Rosenberg. 1989. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol. 142: 3714-3725.
7. Itoh, K., D.C. Platsoucas, and C.M. Balch. 1988. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas: activation by interleukin 2 and autologous tumor cells and involvement of the T cell receptor. J. Exp. Med. 168: 1419-1441.
8. Houghton, A.N. 1994. Commentary: cancer antigens: immune recognition of self and altered self. J. Exp Med. 180: 1-4.
9. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. DePlaen, B. Van Den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254: 1643-1647.
10. Gaugler, B., R Van Den Eynde, P. Van der Bruggen, P. Romero, J. J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp Med. 179: 921-930.
11. Brichard, V., A. Van Pel, T. Wolfel, C, Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489-495.
12. Robbins, P. F., M. El-Gamil, Y. Kawakami, E. Stevens, J. Yannelli, and S. A. Rosenberg. 1994. Recognition of tyrosinase by tumor infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54: 3124-3126.
13. Bakker, A.B.H., M.W.J. Schreurs, A.J. de Boer, Y. Kawakami, S.A. Rosenberg, G.J. Adema, and C.G. Figdor. 1994. Melanocyte lineage-specific antigen gplOO is recognized by melanocyte-derived tumor-infiltrating lymphocytes. J. Exp Med. 179: 1005-1009.
14. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, K. Sakaguchi, E. Appella, J.R. Yannelli, G.J. Adema, T. Miki, and S.A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci.USA. 91: 6458-6462.
15. Kawakami, Y., S. Eliyahu, C.H. Delgaldo, P.F. Robbins, L. Rivoltini, S.L. Topalian, T. Miki, and S.A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl. Acad. Sci. USA. 91: 3515-3519.
16. Coulie, P.G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversari, S. Mattei, E.D. De Plaen, C. Lurquin, J.-P. Szikora, J .-C. Reauld, and T. Boon. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180: 35-42.
17. Halahan, R., and G. Moellmann. 1993. White mutants in mice shedding light on humans. J. Invest. Dermatol. 100 (suppl.): 176S-185S.
18. Mattes, M.J., T.M. Thomson, L.J. Old, and K.O. Lloyd. 1983. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int. J. Cancer. 32: 717-721.
19. Vijayasyradhi, S., B.B. Bouchard, and A.N. Houghton. 1990. The melanoma antigen gp75 is the human homologue to mouse b (BROWN) locus gene. J. Exp Med. 171: 1375-1380.
20. Thomson, T.M., F.X. Real, S. Murakami, C. Cordon-Cardo, L.J. Old, and A.N. Houghton. 1988. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J. Invest. Dermatol. 90: 459-466.
21. Topalian, S., D. Solomon, F.P. Avis, A.E. Chang, D.L. Freerksen, W.M. Linehan, M.T. Lotze, C.N. Robertson, C.A. Seipp, P. Simon, C.G. Simpson, and S.A. Rosenberg. 1988. Immunotherapy of patients with advanced cancer using tumor infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J. Clin. Oncol. 6: 839-853.
22. Ennis, P.D., J. Zemmour, R.D. Salter, and P. Parham. 1990. Rapid cloning of HLA-A, B, CcDNAby using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc. Natl. Acad. Sci. USA. 87: 2833-2837.
23. Horn, S.S., S.L. Topalian, S.T. Simoni, M.J. Mancini, and S.A. Rosenberg. 1991. Common expression of melanoma tumor-associated antigens recognized by human tumor-infiltrating lymphocytes: analysis by human lymphocyte antigen restriction. J. Immunother. 10: 153-164.
24. Marincola, F.M., P. Shamamiam, T.B. Simonis, A. Abati, J. Hackett, T. O’Dea, P. Fetsch, J. Yannelli, N.P. Restifo, J.J. Mule, and S.A. Rosenberg. 1994. Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines. J. Immunother. 16: 13-23.
25. Cohen, T., R.M. Muller, Y. Tomita, and S. Shibahara. 1990. Nucleotide sequence of the cDNA encoding human tyrosinase-related protein. Nucleic Acids Res. 18: 2807-2808.
26. Kwon, B.S., C. Chintamaneni, C.A. Kozak, N.G. Copeland, D.J. Gilbert, N. Jenkins, D. Barton, U. Francke, Y. Kobayashi, and K.K. Kim. 1991. A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc. Natl. Acad. Sci. USA. 88: 9228-9232.
27. Adema, G.J., A.J. de Boer, A.M. Vogell, W.A.M. Loenen, and C.G. Figdor. 1994. Molecular characterization of the melanocyte lineage-specific antigen gplOO. J. Biol. Chem. 269: 20126-20133.
28. Jackson, I., D.M. Chambers, K. Tsukamoto, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, and V. Hearing. 1992. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO (Eur. Mol. Biol. Organ.) J. 11: 527-535.
29. Jackson, I.J. 1988. A cDNA encoding tyrosinase-related protein maps to the brown locus in mice. Proc Natl. Acad. Sci. USA. 85: 4392-4396.
30. Murty, V.W.S. B. Bouchard, S. Mathew, S. Vuayasardhi, and A.N. Houghton. 1992. Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridization. Genomics. 13: 227-229.
31. Jimenez-Cervantes, C., F. Solano, T. Kobayashi, K. Urabe, V.J. Hearing, J.A. Lozano, and J.C. Garcia-Borron. 1994. A new enzymatic function in the melanogenic pathway. J. Biol. Chem. 269: 17993-18001.
32. Parmiani, G. 1993. Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cells. Immunol. Today. 14: 536-538.
33. Nordlund, J.J., J.M. Kirkwood, B.M. Forget, G. Milton, D.M. Albert, and A.B. Lerner. 1983. Vitiligo in patients with metastatic melanoma: a good prognostic sign. J. Am. Acad. Dermatol. 9: 689-696.
34. Bystryn, J.-C., D. Rigel, R.J. Friedman, and A. Kopf. 1987. Prognostic significance of hypopigmentation in malignant melanoma. Arch. Dermatol. 123: 1053-1055.
35. Richards, J.M., N. Mehta, K. Ramming, and P. Skosey. 1992. Sequential chemoimmunotherapy in the treatment of metastatic melanoma. J. Clin. Oncol. 10: 1338-1343.